AddLife (STO:ALIF B) Seems To Use Debt Quite Sensibly
Jan 08
Have your own idea? Try our Stock Screener
Swedish (OMX) Clinical Research and Equipment Industry Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies11
- 7D-6.5%
- 3M-19.1%
- 1Y4.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 5.0%, driven by a pullback from MedCap of 31%. Over the past 12 months, the industry was up 6.5%. Earnings are forecast to grow by 43% annually.
Industry Valuation and Performance
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | SEK 38.5b | SEK 16.7b | -SEK 1,152,911,426.00 | 42.4x | -33.4x | 2.3x |
| Thu, 19 Dec 2024 | SEK 43.6b | SEK 16.7b | -SEK 1,152,911,426.00 | 49.5x | -37.9x | 2.6x |
| Sat, 16 Nov 2024 | SEK 43.1b | SEK 16.8b | -SEK 948,072,426.00 | 47x | -45.5x | 2.6x |
| Mon, 14 Oct 2024 | SEK 47.1b | SEK 16.7b | -SEK 988,175,491.00 | 58.4x | -47.7x | 2.8x |
| Wed, 11 Sep 2024 | SEK 49.4b | SEK 16.7b | -SEK 988,176,492.00 | 60.9x | -50x | 3x |
| Fri, 09 Aug 2024 | SEK 47.4b | SEK 16.7b | -SEK 1,128,120,510.00 | 59.8x | -42x | 2.8x |
| Sun, 07 Jul 2024 | SEK 43.8b | SEK 16.3b | -SEK 1,188,686,510.00 | 57x | -36.8x | 2.7x |
| Tue, 04 Jun 2024 | SEK 43.3b | SEK 16.3b | -SEK 1,188,686,510.00 | 63x | -36.5x | 2.7x |
| Thu, 02 May 2024 | SEK 38.5b | SEK 16.2b | -SEK 1,241,845,705.00 | 37.4x | -31x | 2.4x |
| Sat, 30 Mar 2024 | SEK 40.6b | SEK 16.0b | -SEK 1,122,792,210.00 | 35.6x | -36.2x | 2.5x |
| Mon, 26 Feb 2024 | SEK 38.7b | SEK 15.9b | -SEK 1,122,859,158.00 | 42.6x | -34.5x | 2.4x |
| Wed, 24 Jan 2024 | SEK 37.1b | SEK 15.5b | -SEK 1,393,723,683.00 | 45.2x | -26.6x | 2.4x |
| Fri, 22 Dec 2023 | SEK 36.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 43.4x | -26.5x | 2.4x |
| Sun, 19 Nov 2023 | SEK 33.1b | SEK 15.4b | -SEK 1,398,076,683.00 | 35.5x | -23.6x | 2.1x |
| Tue, 17 Oct 2023 | SEK 23.8b | SEK 15.1b | -SEK 1,134,516,711.00 | 33.1x | -21x | 1.6x |
| Thu, 14 Sep 2023 | SEK 27.8b | SEK 15.1b | -SEK 1,133,713,072.00 | 38.8x | -24.5x | 1.8x |
| Sat, 12 Aug 2023 | SEK 31.7b | SEK 15.1b | -SEK 213,871,038.00 | 46.2x | -148.2x | 2.1x |
| Mon, 10 Jul 2023 | SEK 36.2b | SEK 14.6b | -SEK 172,476,038.00 | 39x | -209.8x | 2.5x |
| Wed, 07 Jun 2023 | SEK 39.8b | SEK 14.6b | -SEK 172,476,038.00 | 39.9x | -230.9x | 2.7x |
| Fri, 05 May 2023 | SEK 39.1b | SEK 14.6b | -SEK 131,406,792.00 | 36.1x | -297.6x | 2.7x |
| Sun, 02 Apr 2023 | SEK 33.1b | SEK 14.6b | -SEK 57,185,459.00 | 32.5x | -578.2x | 2.3x |
| Tue, 28 Feb 2023 | SEK 37.4b | SEK 14.6b | -SEK 59,119,459.00 | 30.6x | -633x | 2.6x |
| Thu, 26 Jan 2023 | SEK 38.8b | SEK 14.2b | SEK 943.9m | 38.5x | 41.1x | 2.7x |
| Sat, 24 Dec 2022 | SEK 38.7b | SEK 14.1b | SEK 944.3m | 40.6x | 40.9x | 2.7x |
| Mon, 21 Nov 2022 | SEK 37.5b | SEK 14.1b | SEK 944.1m | 40.9x | 39.7x | 2.6x |
| Wed, 19 Oct 2022 | SEK 35.3b | SEK 13.5b | SEK 750.9m | 53.3x | 47x | 2.6x |
| Fri, 16 Sep 2022 | SEK 36.7b | SEK 13.5b | SEK 750.9m | 52.9x | 48.8x | 2.7x |
| Sun, 14 Aug 2022 | SEK 46.2b | SEK 13.2b | SEK 667.4m | 48x | 69.3x | 3.5x |
| Tue, 12 Jul 2022 | SEK 47.5b | SEK 13.2b | SEK 753.4m | 41.6x | 63x | 3.6x |
| Thu, 09 Jun 2022 | SEK 54.6b | SEK 13.2b | SEK 753.4m | 47.7x | 72.4x | 4.1x |
| Sat, 07 May 2022 | SEK 49.0b | SEK 12.9b | SEK 749.4m | 45.6x | 65.4x | 3.8x |
| Mon, 04 Apr 2022 | SEK 66.4b | SEK 11.8b | SEK 745.9m | 57.6x | 89x | 5.6x |
| Wed, 02 Mar 2022 | SEK 54.9b | SEK 11.9b | SEK 744.2m | 45.8x | 73.7x | 4.6x |
| Fri, 28 Jan 2022 | SEK 61.8b | SEK 10.8b | SEK 786.3m | 42.2x | 78.6x | 5.7x |
Price to Earnings Ratio
78.6x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 2.9x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 16% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 4.42% | |
| Healthcare | 1.47% | |
| Life Sciences | -6.49% | |
| Clinical Research and Equipment | -6.49% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 139.10 | 3.4% +SEK 560.6m | 31.0% | PE144.9x | |
| BICO BICO Group | SEK 32.12 | 11.9% +SEK 241.4m | -31.9% | PS1x | |
| AROC AroCell | SEK 0.50 | 22.1% +SEK 20.7m | 19.1% | PS2.2x | |
| PRO Promimic | SEK 21.70 | 2.8% +SEK 11.2m | -27.7% | PS9x | |
| MAGLE Magle Chemoswed Holding | SEK 34.80 | -4.9% SEK 9.6m | 32.8% | PE40.8x |
